
Recursion Pharmaceuticals
AI's Impact on Jobs, Technology, and Society
Recursion Pharmaceuticals’ $700 million merger with Exscientia isn’t just a headline—it’s a clarion call for industries worldwide to reimagine established processes with AI innovation, whether revolutionizing drug discovery, redefining political narratives, or reshaping the global job market. AI-Driven Transformation in Biopharma The recent landmark merger between Recursion